These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 35144494)

  • 21. Monitoring of Heart Rate and Activity Using Telemetry Allows Grading of Experimental Procedures Used in Neuroscientific Rat Models.
    Wassermann L; Helgers SOA; Riedesel AK; Talbot SR; Bleich A; Schwabe K; Häger C
    Front Neurosci; 2020; 14():587760. PubMed ID: 33424534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fixed-ratio discrimination training as replacement therapy in Parkinson's disease: studies in a 6-hydroxydopamine-treated rat model.
    Van Keuren KR; Stodgell CJ; Schroeder SR; Tessel RE
    Brain Res; 1998 Jan; 780(1):56-66. PubMed ID: 9473587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the association between blood homocysteine concentration and the degree of behavioral symptoms in the 6-hydroxydopamine-induced Parkinsonism in rat.
    Haghdoost-Yazdi H; Sarookhani M; Faraj A; Fraidouni N; Dargahi T; Yaghoubidoust MH; Azhdari-Zarmehri H
    Pharmacol Biochem Behav; 2014 Sep; 124():297-304. PubMed ID: 24992727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alterations of the nigrostriatal pathway in a 6-OHDA rat model of Parkinson's disease evaluated with multimodal MRI.
    Perlbarg V; Lambert J; Butler B; Felfli M; Valabrègue R; Privat AL; Lehéricy S; Petiet A
    PLoS One; 2018; 13(9):e0202597. PubMed ID: 30188909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Behavior and oxidative stress parameters in rats subjected to the animal's models induced by chronic mild stress and 6-hydroxydopamine.
    Tuon T; Meirelles SS; de Moura AB; Rosa T; Borba LA; Botelho MEM; Abelaira HM; de Mathia GB; Danielski LG; Fileti ME; Petronilho F; Ignácio ZM; Quevedo J; Réus GZ
    Behav Brain Res; 2021 May; 406():113226. PubMed ID: 33684423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Species specific behavioural patterns (digging and swimming) and reaction to novel objects in wild type, Wistar, Sprague-Dawley and Brown Norway rats.
    Stryjek R; Modlińska K; Pisula W
    PLoS One; 2012; 7(7):e40642. PubMed ID: 22815778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of BDNF/TrkB signaling in the effect of diphenyl diselenide on motor function in a Parkinson's disease rat model.
    Sampaio TB; Pinton S; da Rocha JT; Gai BM; Nogueira CW
    Eur J Pharmacol; 2017 Jan; 795():28-35. PubMed ID: 27915043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroprotective effects of a selective N-methyl-D-aspartate NR2B receptor antagonist in the 6-hydroxydopamine rat model of Parkinson's disease.
    Leaver KR; Allbutt HN; Creber NJ; Kassiou M; Henderson JM
    Clin Exp Pharmacol Physiol; 2008 Nov; 35(11):1388-94. PubMed ID: 18785982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced glutamate, IP3 and cAMP activity in the cerebral cortex of unilateral 6-hydroxydopamine induced Parkinson's rats: effect of 5-HT, GABA and bone marrow cell supplementation.
    Nandhu MS; Paul J; Kuruvilla KP; Malat A; Romeo C; Paulose CS
    J Biomed Sci; 2011 Jan; 18(1):5. PubMed ID: 21235809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of experimental rat models of early brain injury after subarachnoid hemorrhage.
    Lee JY; Sagher O; Keep R; Hua Y; Xi G
    Neurosurgery; 2009 Aug; 65(2):331-43; discussion 343. PubMed ID: 19625913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Standard analgesics reverse burrowing deficits in a rat CCI model of neuropathic pain, but not in models of type 1 and type 2 diabetes-induced neuropathic pain.
    Rutten K; Gould SA; Bryden L; Doods H; Christoph T; Pekcec A
    Behav Brain Res; 2018 Sep; 350():129-138. PubMed ID: 29738803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Asymmetry of sympathetic activity in a rat model of Parkinson's disease induced by 6-hydroxydopamine: haemodynamic, electrocardiographic and biochemical changes.
    Turgut M
    Res Exp Med (Berl); 1998; 197(5):281-92. PubMed ID: 9561558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cross-centre replication of suppressed burrowing behaviour as an ethologically relevant pain outcome measure in the rat: a prospective multicentre study.
    Wodarski R; Delaney A; Ultenius C; Morland R; Andrews N; Baastrup C; Bryden LA; Caspani O; Christoph T; Gardiner NJ; Huang W; Kennedy JD; Koyama S; Li D; Ligocki M; Lindsten A; Machin I; Pekcec A; Robens A; Rotariu SM; Vo S; Segerdahl M; Stenfors C; Svensson CI; Treede RD; Uto K; Yamamoto K; Rutten K; Rice AS
    Pain; 2016 Oct; 157(10):2350-65. PubMed ID: 27643836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PET imaging with [
    Tang J; Xu Y; Liu C; Fang Y; Cao S; Zhao C; Huang H; Zou M; Chen Z
    Nucl Med Biol; 2020; 90-91():1-9. PubMed ID: 32861175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Burrowing behavior as an indicator of post-laparotomy pain in mice.
    Jirkof P; Cesarovic N; Rettich A; Nicholls F; Seifert B; Arras M
    Front Behav Neurosci; 2010; 4():165. PubMed ID: 21031028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Behavioural supersensitivity following neonatal 6-hydroxydopamine: attenuation by MK-801.
    Archer T; Fredriksson A
    Neurotox Res; 2007 Sep; 12(2):113-24. PubMed ID: 17967735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glucagon-like peptide 1 receptor stimulation reverses key deficits in distinct rodent models of Parkinson's disease.
    Harkavyi A; Abuirmeileh A; Lever R; Kingsbury AE; Biggs CS; Whitton PS
    J Neuroinflammation; 2008 May; 5():19. PubMed ID: 18492290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Attenuation by Nardostachys jatamansi of 6-hydroxydopamine-induced parkinsonism in rats: behavioral, neurochemical, and immunohistochemical studies.
    Ahmad M; Yousuf S; Khan MB; Hoda MN; Ahmad AS; Ansari MA; Ishrat T; Agrawal AK; Islam F
    Pharmacol Biochem Behav; 2006 Jan; 83(1):150-60. PubMed ID: 16500697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The corticotrophin-releasing factor-like peptide urocortin reverses key deficits in two rodent models of Parkinson's disease.
    Abuirmeileh A; Lever R; Kingsbury AE; Lees AJ; Locke IC; Knight RA; Chowdrey HS; Biggs CS; Whitton PS
    Eur J Neurosci; 2007 Jul; 26(2):417-23. PubMed ID: 17650114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Orofacial neuropathic pain reduces spontaneous burrowing behavior in rats.
    Deseure K; Hans G
    Physiol Behav; 2018 Jul; 191():91-94. PubMed ID: 29673859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.